BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16495928)

  • 1. Clinicopathological significance of mitochondrial D-Loop mutations in head and neck carcinoma.
    Lièvre A; Blons H; Houllier AM; Laccourreye O; Brasnu D; Beaune P; Laurent-Puig P
    Br J Cancer; 2006 Mar; 94(5):692-7. PubMed ID: 16495928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical value of mitochondrial mutations in colorectal cancer.
    Lièvre A; Chapusot C; Bouvier AM; Zinzindohoué F; Piard F; Roignot P; Arnould L; Beaune P; Faivre J; Laurent-Puig P
    J Clin Oncol; 2005 May; 23(15):3517-25. PubMed ID: 15908662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
    Quintela-Fandino M; Hitt R; Medina PP; Gamarra S; Manso L; Cortes-Funes H; Sanchez-Cespedes M
    J Clin Oncol; 2006 Sep; 24(26):4333-9. PubMed ID: 16896002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCND1 amplification predicts sensitivity to chemotherapy and chemoradiotherapy in head and neck squamous cell carcinoma.
    Ishiguro R; Fujii M; Yamashita T; Tashiro M; Tomita T; Ogawa K; Kameyama K
    Anticancer Res; 2003; 23(6D):5213-20. PubMed ID: 14981992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors.
    Sanchez-Cespedes M; Parrella P; Nomoto S; Cohen D; Xiao Y; Esteller M; Jeronimo C; Jordan RC; Nicol T; Koch WM; Schoenberg M; Mazzarelli P; Fazio VM; Sidransky D
    Cancer Res; 2001 Oct; 61(19):7015-9. PubMed ID: 11585726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in the mitochondrial displacement loop in lung cancers.
    Suzuki M; Toyooka S; Miyajima K; Iizasa T; Fujisawa T; Bekele NB; Gazdar AF
    Clin Cancer Res; 2003 Nov; 9(15):5636-41. PubMed ID: 14654546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.
    Chung CH; Ely K; McGavran L; Varella-Garcia M; Parker J; Parker N; Jarrett C; Carter J; Murphy BA; Netterville J; Burkey BB; Sinard R; Cmelak A; Levy S; Yarbrough WG; Slebos RJ; Hirsch FR
    J Clin Oncol; 2006 Sep; 24(25):4170-6. PubMed ID: 16943533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial mutations are a late event in the progression of head and neck squamous cell cancer.
    Mithani SK; Taube JM; Zhou S; Smith IM; Koch WM; Westra WH; Califano JA
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4331-5. PubMed ID: 17671113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial DNA alterations in thyroid cancer.
    Tong BC; Ha PK; Dhir K; Xing M; Westra WH; Sidransky D; Califano JA
    J Surg Oncol; 2003 Mar; 82(3):170-3. PubMed ID: 12619060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
    Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
    Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial C-tract alteration in premalignant lesions of the head and neck: a marker for progression and clonal proliferation.
    Ha PK; Tong BC; Westra WH; Sanchez-Cespedes M; Parrella P; Zahurak M; Sidransky D; Califano JA
    Clin Cancer Res; 2002 Jul; 8(7):2260-5. PubMed ID: 12114429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy followed by limited surgery in a mouse model of head and neck cancer.
    Lee JJ; Hah JH; Im SA; Kim SY; Sung MW; Kim KH; Heo DS
    Anticancer Res; 2009 Jan; 29(1):255-9. PubMed ID: 19331158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and molecular characterization of head and neck squamous cell lines of fanconi anemia patients.
    van Zeeburg HJ; Snijders PJ; Pals G; Hermsen MA; Rooimans MA; Bagby G; Soulier J; Gluckman E; Wennerberg J; Leemans CR; Joenje H; Brakenhoff RH
    Cancer Res; 2005 Feb; 65(4):1271-6. PubMed ID: 15735012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of mitochondrial DNA alterations in esophageal squamous cell carcinomas.
    Lin CS; Chang SC; Wang LS; Chou TY; Hsu WH; Wu YC; Wei YH
    J Thorac Cardiovasc Surg; 2010 Jan; 139(1):189-197.e4. PubMed ID: 19660406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial DNA mutations and 8-hydroxy-2'-deoxyguanosine Content in Japanese patients with urinary bladder and renal cancers.
    Wada T; Tanji N; Ozawa A; Wang J; Shimamoto K; Sakayama K; Yokoyama M
    Anticancer Res; 2006; 26(5A):3403-8. PubMed ID: 17094459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 alterations predict tumor response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma: a prospective series.
    Cabelguenne A; Blons H; de Waziers I; Carnot F; Houllier AM; Soussi T; Brasnu D; Beaune P; Laccourreye O; Laurent-Puig P
    J Clin Oncol; 2000 Apr; 18(7):1465-73. PubMed ID: 10735894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
    Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy in head and neck cancer: should it be revisited?
    Specenier PM; Vermorken JB
    Cancer Lett; 2007 Oct; 256(2):166-77. PubMed ID: 17673364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma.
    Gunduz E; Gunduz M; Beder L; Nagatsuka H; Fukushima K; Sutcu R; Delibas N; Yamanaka N; Shimizu K; Nagai N
    Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):254-60. PubMed ID: 19289703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.